Despite the longstanding recognition of the spectral nature of human d
isease due to lymphatic filariasis, immunologists interested in pathog
enesis have mostly examined patients classified as being at either one
extreme pole or the other. While the clinically asymptomatic individu
als with microfilaremia who sit at one pole always have active infecti
on, it has been difficult to define who else on the clinical spectrum
is actively infected with living adult worms. In this review, David Fr
eedman discusses how the ability to measure circulating filarial antig
en in patient serum has advanced our ability to understand the immunop
athogenesis of lymphatic filariasis by improving the precision of pati
ent classification. Recent work suggests that the presence (or absence
) of antigenemia, rather than overt clinical manifestations of disease
, is closely associated with specific cytokine responses. A framework
for patient classification based on these findings is proposed.